Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2) Active Not Recruiting Phase 2 Trials for Tacrolimus (DB00864)

Also known as: Myelodysplastic Syndrome With Excess Blasts-2

IndicationStatusPhase
DBCOND0092771 (Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02220985Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHDTreatment